tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CMPS Stock Latest News

Cathie Wood Marks Independence Day with Strategic Buys and a Major Sell-Off
Market NewsCathie Wood Marks Independence Day with Strategic Buys and a Major Sell-Off
5d ago
ARKG
ARKK
Cathie Wood’s ARK Investment buys 29K shares of Compass Pathways today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 29K shares of Compass Pathways today
5d ago
CMPS
Psychedelic: Compass Pathways achieves primary endpoint in COMP360 trial
PremiumThe Fly
Psychedelic: Compass Pathways achieves primary endpoint in COMP360 trial
13d ago
CMND
CMPS
Mike Davis to become CDER deputy director, Pink Sheet’s Gingery says
PremiumThe Fly
Mike Davis to become CDER deputy director, Pink Sheet’s Gingery says
15d ago
ATAI
CMND
Compass Pathways price target lowered to $7 from $12 at BTIG
PremiumThe Fly
Compass Pathways price target lowered to $7 from $12 at BTIG
15d ago
CMPS
Compass Pathways weakness a buying opportunity, says Canaccord
PremiumThe FlyCompass Pathways weakness a buying opportunity, says Canaccord
15d ago
CMPS
Compass Pathways Achieves Phase 3 Trial Success
Premium
Company Announcements
Compass Pathways Achieves Phase 3 Trial Success
16d ago
8K
CMPS
Compass Pathways downgraded to In Line from Outperform at Evercore ISI
Premium
The Fly
Compass Pathways downgraded to In Line from Outperform at Evercore ISI
16d ago
CMPS
MNMD
Compass Pathways results ‘historic first’ for psychedelics, says H.C. Wainwright
PremiumThe Fly
Compass Pathways results ‘historic first’ for psychedelics, says H.C. Wainwright
16d ago
CMPS
Compass Pathways weakness ‘significantly overdone,’ says Stifel
PremiumThe Fly
Compass Pathways weakness ‘significantly overdone,’ says Stifel
16d ago
CMPS
Compass Pathways achieves primary endpoint in Phase 3 trial of COMP360
PremiumThe Fly
Compass Pathways achieves primary endpoint in Phase 3 trial of COMP360
16d ago
CMPS
Trump Trade: President said to weigh possible U.S. strike against Iran
PremiumThe Fly
Trump Trade: President said to weigh possible U.S. strike against Iran
21d ago
F
F
Psychedelic advocates hopeful Trump administration will support space, STAT says
PremiumThe FlyPsychedelic advocates hopeful Trump administration will support space, STAT says
21d ago
ATAI
CMND
COMPASS Pathways Approves Key Resolutions at AGM
Premium
Company Announcements
COMPASS Pathways Approves Key Resolutions at AGM
26d ago
8K
CMPS
Compass Pathways assumed with an Overweight at Cantor Fitzgerald
Premium
The Fly
Compass Pathways assumed with an Overweight at Cantor Fitzgerald
1M ago
CMPS
Positive Outlook for COMPASS Pathways Amid Promising Clinical Developments and Strong Financial Position
PremiumRatings
Positive Outlook for COMPASS Pathways Amid Promising Clinical Developments and Strong Financial Position
2M ago
CMPS
Positive Outlook for COMPASS Pathways: Buy Rating Backed by Promising Developments in Mental Health Treatments and Strong Financial Position
PremiumRatings
Positive Outlook for COMPASS Pathways: Buy Rating Backed by Promising Developments in Mental Health Treatments and Strong Financial Position
2M ago
CMPS
Buy Rating Reiterated for COMPASS Pathways: Promising Phase 3 Trials and Strong Financial Position Highlighted
PremiumRatings
Buy Rating Reiterated for COMPASS Pathways: Promising Phase 3 Trials and Strong Financial Position Highlighted
2M ago
CMPS
Compass Pathways Reports Improved Quarterly Results
PremiumCompany Announcements
Compass Pathways Reports Improved Quarterly Results
2M ago
CMPS
Compass Pathways’ Earnings Call Highlights Progress and Challenges
PremiumCompany AnnouncementsCompass Pathways’ Earnings Call Highlights Progress and Challenges
2M ago
CMPS
Positive Outlook for COMPASS Pathways: Strong Clinical Progress and Financial Stability Support Buy Rating
Premium
Ratings
Positive Outlook for COMPASS Pathways: Strong Clinical Progress and Financial Stability Support Buy Rating
2M ago
CMPS
Psychedelic: Compass, GH Research, MindMed report quarterly earnings
Premium
The Fly
Psychedelic: Compass, GH Research, MindMed report quarterly earnings
2M ago
CMPS
CYBN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >